EW vs STRD · P/E 47, rev $1.39B vs rev $463.5M
Edwards Lifesciences Corp (EW) versus MicroStrategy Incorporated 10.00% Series A Perpetual Stride Preferred Stock (STRD) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
MicroStrategy Incorporated 10.00% Series A Perpetual Stride Preferred Stock (STRD) is a software - application company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported STRD revenue for 2024-12-31 was $463.5M. Net income was -$1.17B. Revenue was down 6.6% from 2023-12-31 to 2024-12-31. STRD currently screens at market cap $901.8M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. STRD currently screens at market cap $901.8M.
Not investment advice. Open the EW and STRD stock pages for the full models.
Not investment advice.